About Annexon Biosciences
Unlocking the next generation of complement therapies We are focused on stopping C1q, the initiating molecule of the classical complement pathway, at the start to treat devastating autoimmune, neurodegenerative, and ophthalmic diseases of the body, brain and eye. Our science We target C1q to block all damaging components of the immune system’s classical complement pathway. Learn more Our pipeline […]
2 Job openings in Annexon Biosciences
Sr. Director, Quality Assurance
245000 - 273000
Company:At Annexon Biosciences we are a biopharmaceutical company advancing a latestage clinical platform of novel therapies for people living with devastating classical complementmediated neuroinflammatory diseases of the body brain and eye. Our novel scientific approach targets upst More...
Senior Director Biostatistics
272000 - 302000
Company:At Annexon Biosciences we are a biopharmaceutical company advancing a latestage clinical platform of novel therapies for people living with devastating classical complementmediated neuroinflammatory diseases of the body brain and eye. Our novel scientific approach targets upst More...
